Diabetes - Keren Zhou

. .

Auteur(s) : Keren Zhou - M. Cecilia Lansang - Richard David Leslie - Tahseen A. Chowdhury

Editeur : Taylor & Francis Ltd

Langue : Anglais

Parution : 01/11/2022

Format : Moyen, de 350g à 1kg

Nombre de pages : 244

Expédition : 610

Dimensions : 24.9 x 17.4 x 1.3

ISBN : 9781032146454

Résumé :

The book explains the underlying pathophysiology of the disease and covers in detail all its main forms and complications. Separate chapters consider the range of treatment options, together with summaries of key clinical trials. Coverage also includes epidemiology and classification, as well as diagnosis, screening, limiting risk, and other aspects of disease management and patient care. The book is illustrated throughout by explanatory diagrams, graphs, tables, and photos.

Key Features:

1. Builds on its strength of having excellent content on long-term management of hyperglycemia by including pancreas and islet transplantation.

2. Contains invaluable information on glucose monitoring for healthcare professionals interested in diabetes.

...

Biographie:

Preface. Acknowledgements. Author biographies. Abbreviations. The nature of diabetes. Glucose, insulin, and diabetes. Type 1 diabetes. Type 2 diabetes. Diabetes screening and patient care. Diabetes and vascular disease. Diabetic neuropathy. Diabetic eye disease. Diabetic kidney disease. Skin and musculoskeletal complications of diabetes. Infections and diabetes. Severe diabetic metabolic disturbances. Long-term management of hyperglycemia. Noninsulin therapies. Insulin treatment and pancreatic/islet cell transplantation. Special management considerations. References. Resources. Glossary. Index.

Sommaire:

M. Cecilia Lansang is Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, and director of Endocrinology at the Main Campus of Cleveland Clinic, Ohio, USA. She had her endocrine clinical and research fellowship training at the Brigham and Women's Hospital where she stayed on as staff before moving to the University of Florida, and then to Cleveland Clinic. She obtained her degree in Master of Public Health at the Harvard School of Public Health. She is active in research and medical education, serves on journal editorial boards, and focuses clinical work on kidney transplant, inpatient diabetes, and technology.

David Leslie is Professor of Diabetes and Autoimmunity at the Blizard Institute, University of London and Honorary Consultant Physician at St Bartholomews and the Royal London Hospitals, London, UK and Lead Professor on the International Medical Faculty, Campus Biomedico, University of Rome, Italy. He has published 12 books and more than 250 peer-reviewed papers, He was Principle Investigator of three major EU programmes, Wellcome Trust Senior Fellow in Clinical Science and formerly President of the Association of Physicians of Great Britain and Ireland. He has held Visiting Chairs in USA (Chicago and Kansas) and is Emeritus Professor in China (Central South University).

Tahseen Chowdhury is a Clinician in the Department of Diabetes and Metabolism at the Royal London Hospital, in the East End of London. He runs a large specialist Diabetes and Metabolism unit, dealing with diabetes particularly amongst the Bangladeshi community of Tower Hamlets. He has a research / clinical interest in diabetes in South Asians and diabetic kidney disease, and has authored many publications, including books entitled Diabetes in South Asian people: Explained, Fatty Liver and Diabetes Management in Clinical Practice. He is Honorary Professor at Barts and the London School of Medicine and Dentistry in London, where he runs the metabolism programme for medical students. He qualified from the University of Birmingham and trained in Birmingham and Manchester, before becoming a Consultant Physician in 2000.

Keren Zhou completed her medical degree at Case Western Reserve University. She subsequently trained in Internal Medicine and Endocrinology at the Cleveland Clinic in Ohio, USA, where she is currently staff in the Endocrinology and Metabolism Institute and a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University. She serves as the Research Director for the Institute and a principal investigator on a number of studies related to diabetes and diabetes technology.